Results 101 to 110 of about 258,588 (271)
Plasmodium vivax liver stage assay platforms using Indian clinical isolates
Background Vivax malaria is associated with significant morbidity and economic loss, and constitutes the bulk of malaria cases in large parts of Asia and South America as well as recent case reports in Africa.
Pradeep A. Subramani +19 more
doaj +1 more source
Vivax malaria relapses frequently even in low-transmission settings. Chloroquine delays but does not prevent recurrences. Adding primaquine to a slowly eliminated schizonticide significantly reduces recurrences and improves hematocrit, but this advantage
C. Chu +20 more
semanticscholar +1 more source
A Machine Learning‐Based Dynamic SST Index for Long‐Lead Malaria Prediction in the Peruvian Amazon
Abstract Malaria imposes a major health burden in the Peruvian Amazon, and its early warning is essential for effective disease prevention. The tropical sea surface temperature (SST) variability, fundamentally shaping the global weather patterns, may also alter malaria transmission and potentially improve its long‐lead predictability. In this study, we
Mengxin Pan +7 more
wiley +1 more source
Imported Plasmodium vivax Malaria ex Pakistan [PDF]
According to WHO, 1.5 million cases of malaria are reported annually in Pakistan. Malaria distribution in Pakistan is heterogeneous, and some areas, including Punjab, are considered at low risk for malaria. The aim of this study is to describe the trend of imported malaria cases from Pakistan reported to the international surveillance systems from 2005
Odolini, Silvia +8 more
openaire +3 more sources
Malaria is a vector-borne infectious disease, caused by five different species of the genus Plasmodium, and is endemic to many tropical and sub-tropical countries of the globe.
Nisha Siwal +9 more
semanticscholar +1 more source
Sex in Immune Cells and Parasitic Diseases — A Complex Relationship
ABSTRACT Epidemiological studies consistently show that many parasitic diseases affect males more frequently than females. These disparities are multifactorial, arising partly from gender‐specific behaviors that influence exposure risk and health‐seeking practices, especially in low‐ and middle‐income countries. Increasing evidence also highlights that
Barbara Honecker +2 more
wiley +1 more source
Artemisinin combination therapy for vivax malaria [PDF]
Early parasitological diagnosis and treatment with artemisinin-based combination therapies (ACTs) are key components of worldwide malaria elimination programmes. In general, use of ACTs has been limited to patients with falciparum malaria whereas blood-stage infections with Plasmodium vivax are mostly still treated with chloroquine.
Douglas, N +4 more
openaire +3 more sources
Malaria in Nigeria is principally due to Plasmodium falciparum and, to a lesser extent to Plasmodium malariae and Plasmodium ovale. Plasmodium vivax is thought to be absent in Nigeria in particular and sub-Saharan Africa in general, due to the near ...
Mary M. Oboh +6 more
semanticscholar +1 more source
Immune Modulation by Plasmodium yoelii: Insights From Lethal and Non‐Lethal Strains
ABSTRACT Malaria pathogenesis is driven by intricate host–parasite interactions that determine immune balance and clinical outcome. The Plasmodium yoelii model, particularly its lethal (17XL) and non‐lethal (17XNL) strains, provides a robust framework to investigate these dynamics.
Sharoen Yu Ming Lim
wiley +1 more source
Distinct inflammatory profile underlies pathological increases in creatinine levels associated with Plasmodium vivax malaria clinical severity. [PDF]
Although Plasmodium vivax infection is a frequent cause of malaria worldwide, severe presentations have been more regularly described only in recent years.
Luís A B Cruz +2 more
doaj +1 more source

